10x Genomics Shares Dive on Weaker-Than-Expected Guidance

Text size Dreamstime Shares of the lab tools firm 10x Genomics slid by nearly a quarter in premarket trading on Thursday, the day after the company reported financial results and issued guidance that fell well short of Wall Street expectations. Late Wednesday, the company reported revenue of $143.5 million for the fourth quarter of 2021, …

10x Genomics Shares Dive on Weaker-Than-Expected Guidance Read More »